Published Erratum
doi: 10.1016/S2213-2600(21)00093-X.
Epub 2021 Feb 16.
Correction to Lancet Respir Med 2021; published online Jan 28. https://doi.org/10.1016/S2213-2600(20)30517-8
- PMID: 33607008
- DOI: 10.1016/S2213-2600(21)00093-X
Item in Clipboard
Published Erratum
Correction to Lancet Respir Med 2021; published online Jan 28. https://doi.org/10.1016/S2213-2600(20)30517-8
Lancet Respir Med.
2021 Apr.
No abstract available
Erratum for
-
Long-term safety and efficacy of lumacaftor-ivacaftor therapy in children aged 6-11 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a phase 3, open-label, extension study.Lancet Respir Med. 2021 Jul;9(7):721-732. doi: 10.1016/S2213-2600(20)30517-8. Epub 2021 Jan 28. Lancet Respir Med. 2021. PMID: 33516285 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
